AzTrials
AzTrials

Sleep FragmentationSDINCT02843737

Multicenter Observational Study to Validate a New Index for Sleep Fragmentation Analysis: Sleep Diversity Index (SDI)

An observational study of Sleep Fragmentation, run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators want to validate the Sleep Diversity Index as a diagnosis tool of sleep fragmentation on 405 patients who will perform a polysomnography under spontaneous breathing. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sleep Fragmentation
What is being tested?
Polysomnography under spontaneous breathing
How many people
300 participants
Where
3 sitesFrance
Study dates
21 Nov 2014to 16 Mar 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who performed a spontaneous breathing polysomnography

Who may be able to join

  • Spontaneous polysomnography

Who cannot join

  • Insomnia
  • Patients with psychoactive drug having an important effect on sleep

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • CHU Dijon

    Dijon, 21079

  • CHU Poitiers

    Poitiers, 86021

  • Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (CHITS)

    Toulon, 83056

Other trials in France

About this study

The investigators want to validate the Sleep Diversity Index as a diagnosis tool of sleep fragmentation on 405 patients who will perform a polysomnography under spontaneous breathing.

Read the detailed description

Sleep fragmentation is one of the main problems of sleep disorders especially in respiratory failure. During this last decade, several indicators of sleep fragmentation were introduced but none of them seems to take into account the succession of sleep stages. To tackle with this problem, The investigators used the Shannon entropy index for modelling sleep stages diversity from an hypnogram and for assessing more accurately sleep quality by quantifying its fragmentation. The investigators developed a new tool we called Sleep Diversity Index (SDI).

In a retrospective study, the investigators calculated Sleep diversity index for 55 healthy subjects and 56 patients with suspected sleep apnea syndrom. Using the receiver operating characteristic (ROC) curves the threshold of fragmentation was determined at 20%. If SDI is lower than 20%, then sleep is considered as non-fragmented and otherwise, sleep is considered as fragmented.

To validate our SDI it is necessary to compare this diagnosis tool to a "gold standard" based on the clinician diagnosis and a mathematical diagnosis index created from objective criteria of polysomnography. The investigators propose a multicenter study to validate the SDI as a diagnosis tool of sleep fragmentation.

Being tested
Polysomnography under spontaneous breathing
Medical subject headings
Sleep Deprivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Polysomnography under spontaneous breathingOther

    Patient will come to the sleep laboratory to perform the polysomnography under spontaneous breathing prescribed by the clinician

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison between mathematical analysis and clinician interpretation of polysomnographic datas recorded under spontaneous breathing

    In order to determine the fragmentation of patient's sleep with two different approach and test the sleep diversity index .

    Measured: One night

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2016 (estimated)
  2. Study start21 Nov 2014
  3. Primary completionDec 2014
  4. Study completion16 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02843737
Sponsor's protocol ID
CH-2014-02 / IDS 2
Acronym
SDI
Status last verified
May 2017
First submitted
20 Jul 2016
Last updated
12 May 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Fragmentation, run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison between mathematical analysis and clinician interpretation of polysomnographic datas recorded under spontaneous breathing (time frame: One night). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in